Document is current
Any future updates will be listed below
-
Authors
Pozo Garcia, Victoria
Çobanoğlu, Tuğçe S.
Hammer, Helen Sophie
Carlota, Rita
Holm, Kasper
Verfaillie, Catherine
Poetz, Oliver
Jennings, Paul
Moco, Sofia https://orcid.org/0000-0001-8170-8876
-
Funding
Funding for this research was provided by:
EU RISK-HUNT3R (964537)
- License Information
-
More Information
Article History
Received: 18 April 2025
Accepted: 15 July 2025
First Online: 12 August 2025
Declarations
:
: OP is a shareholder of SIGNATOPE GmbH. SIGNATOPE offers assay development and service using immunoaffinity LC–MS/MS technology. All the other authors declare no conflict of interest.
